BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20035131)

  • 21. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.
    Emerich DF; Snodgrass P; Dean R; Agostino M; Hasler B; Pink M; Xiong H; Kim BS; Bartus RT
    Br J Cancer; 1999 Jun; 80(7):964-70. PubMed ID: 10362103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
    Kondo A; Goldman S; Lulla RR; Mania-Farnell B; Vanin EF; Sredni ST; Rajaram V; Soares MB; Tomita T
    J Neurosurg Pediatr; 2009 Dec; 4(6):592-8. PubMed ID: 19951051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral injection of thermogelling and sustained-release carboplatin-loaded hydrogel simplifies the administration and remains the synergistic effect with radiotherapy for mice gliomas.
    Liang HT; Lai XS; Wei MF; Lu SH; Wen WF; Kuo SH; Chen CM; Tseng WI; Lin FH
    Biomaterials; 2018 Jan; 151():38-52. PubMed ID: 29059540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.
    Shi M; Anantha M; Wehbe M; Bally MB; Fortin D; Roy LO; Charest G; Richer M; Paquette B; Sanche L
    J Nanobiotechnology; 2018 Oct; 16(1):77. PubMed ID: 30290821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model.
    Mathieu D; Lecomte R; Tsanaclis AM; Larouche A; Fortin D
    Can J Neurol Sci; 2007 Aug; 34(3):296-306. PubMed ID: 17803026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas.
    Cloughesy TF; Black KL; Gobin YP; Farahani K; Nelson G; Villablanca P; Kabbinavar F; Viñeula F; Wortel CH
    Neurosurgery; 1999 Feb; 44(2):270-8; discussion 278-9. PubMed ID: 9932880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
    Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
    PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.
    Gregor A; Lind M; Newman H; Grant R; Hadley DM; Barton T; Osborn C
    J Neurooncol; 1999 Sep; 44(2):137-45. PubMed ID: 10619497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
    Bartus RT; Snodgrass P; Marsh J; Agostino M; Perkins A; Emerich DF
    J Pharmacol Exp Ther; 2000 Jun; 293(3):903-11. PubMed ID: 10869391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma.
    Elleaume H; Barth RF; Rousseau J; Bobyk L; Balosso J; Yang W; Huo T; Nakkula R
    J Neurooncol; 2020 Sep; 149(2):193-208. PubMed ID: 32809095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.
    Hua Y; Tang LL; Fewel ME; Keep RF; Schallert T; Muraszko KM; Hoff JT; Xi GH
    Acta Neurochir Suppl; 2005; 95():403-6. PubMed ID: 16463890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures.
    Qureshi AI; Suri MF; Khan J; Sharma M; Olson K; Guterman LR; Hopkins LN
    J Neurooncol; 2001 Jan; 51(2):151-8. PubMed ID: 11386412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intralesional mitoxantrone biopolymer-mediated chemotherapy prolongs survival in rats with experimental brain tumors.
    Saini M; Roser F; Hussein S; Samii M; Bellinzona M
    J Neurooncol; 2004 Jul; 68(3):225-32. PubMed ID: 15332325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
    Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
    Wang JL; Barth RF; Cavaliere R; Puduvalli VK; Giglio P; Lonser RR; Elder JB
    PLoS One; 2020; 15(12):e0244383. PubMed ID: 33373402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.
    de Souza PC; Balasubramanian K; Njoku C; Smith N; Gillespie DL; Schwager A; Abdullah O; Ritchey JW; Fung KM; Saunders D; Jensen RL; Towner RA
    J Magn Reson Imaging; 2015 Dec; 42(6):1582-91. PubMed ID: 25920494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.
    Shi M; Fortin D; Paquette B; Sanche L
    Invest New Drugs; 2016 Jun; 34(3):269-76. PubMed ID: 26961906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A surgical technique for safely placing a drug delivery catheter into the pons of primates: preliminary results of carboplatin infusion.
    Storm PB; Clatterbuck RE; Liu YJ; Johnson RM; Gillis EM; Guarnieri M; Carson BS
    Neurosurgery; 2003 May; 52(5):1169-76; discussion 1176-7. PubMed ID: 12699562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.